So, once youve already plateaued and stop losing weight, do you keep taking it, even though you get no further weight-loss benefit, but the potential for harm continues to accumulate
Clinical Insights Retatrutide may lead to: Up to 24% reduction in total body weight over 48 weeks in individuals with obesity Improvements in glycemic control and liver health Promising outcomes for patients with insulin resistance and advanced metabolic conditions (Source: Eli Lilly clinical trial data
Join the 10 million people who have already experienced the most personal care at their fingertips
New research from 23and ME sheds a light on why GLP-1 weight-loss drugs work differently across patients, with two studies suggesting that genetic variation and cardiovascular mechanisms independent of weight loss may both play significant roles in determining individual outcomes
If a proposal from the Trump administration is implemented, it could be covered by Medicare, the U.S
This could lead to broader changes in population health management and overarching changes in health system needs